Vanguard Group Inc. cut its holdings in Dolby Laboratories (NYSE:DLB - Free Report) by 0.5% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,720,542 shares of the electronics maker's stock after selling 36,382 shares during the period. Vanguard Group Inc. owned approximately 8.08% of Dolby Laboratories worth $495,813,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Concurrent Investment Advisors LLC bought a new position in shares of Dolby Laboratories during the fourth quarter worth approximately $327,000. Teacher Retirement System of Texas boosted its stake in shares of Dolby Laboratories by 19.1% in the fourth quarter. Teacher Retirement System of Texas now owns 115,772 shares of the electronics maker's stock valued at $7,435,000 after buying an additional 18,579 shares during the period. M&T Bank Corp boosted its stake in shares of Dolby Laboratories by 625.2% in the fourth quarter. M&T Bank Corp now owns 103,278 shares of the electronics maker's stock valued at $6,633,000 after buying an additional 89,036 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH grew its position in Dolby Laboratories by 7.3% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 48,006 shares of the electronics maker's stock worth $3,091,000 after buying an additional 3,264 shares in the last quarter. Finally, Evergreen Capital Management LLC increased its stake in Dolby Laboratories by 40.6% during the 4th quarter. Evergreen Capital Management LLC now owns 6,336 shares of the electronics maker's stock worth $407,000 after acquiring an additional 1,828 shares during the period. 58.56% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several equities analysts have weighed in on DLB shares. Rosenblatt Securities reaffirmed a "buy" rating and issued a $85.00 price objective on shares of Dolby Laboratories in a report on Friday, January 30th. Wall Street Zen lowered Dolby Laboratories from a "buy" rating to a "hold" rating in a report on Saturday, January 31st. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, April 27th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $90.75.
Get Our Latest Stock Report on Dolby Laboratories
Insider Activity
In other news, SVP Shriram Revankar sold 3,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $66.14, for a total value of $198,420.00. Following the sale, the senior vice president directly owned 83,218 shares in the company, valued at approximately $5,504,038.52. This trade represents a 3.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Ryan Nicholson sold 2,667 shares of Dolby Laboratories stock in a transaction that occurred on Friday, February 13th. The shares were sold at an average price of $66.38, for a total transaction of $177,035.46. Following the sale, the chief accounting officer directly owned 36,956 shares in the company, valued at $2,453,139.28. This trade represents a 6.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 37.93% of the stock is currently owned by insiders.
Dolby Laboratories Price Performance
Shares of DLB opened at $59.16 on Wednesday. The firm has a 50 day simple moving average of $62.48 and a two-hundred day simple moving average of $64.42. Dolby Laboratories has a one year low of $55.73 and a one year high of $78.28. The company has a market cap of $5.65 billion, a P/E ratio of 23.38 and a beta of 0.86.
Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, beating analysts' consensus estimates of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The firm had revenue of $395.63 million for the quarter, compared to the consensus estimate of $385.80 million. During the same quarter last year, the business posted $1.34 EPS. The company's revenue was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, analysts expect that Dolby Laboratories will post 3.17 earnings per share for the current fiscal year.
Dolby Laboratories Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th will be given a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Tuesday, May 12th. Dolby Laboratories's payout ratio is currently 56.92%.
Dolby Laboratories Profile
(
Free Report)
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company's core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby's licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report